Immunosuppressive effect of vasoactive peptides derived from human fibrinogen.
D000818:Animals; D002455:Cell Division; D003208:Concanavalin A / Q000494:pharmacology; D005338:Fibrin Fibrinogen Degradation Products; D005340:Fibrinogen; D005768:Gastrointestinal Hormones / Q000494:pharmacology*; D006801:Humans; D007166:Immunosuppressive Agents; D008070:Lipopolysaccharides / Q000494:pharmacology; D008297:Male; D051379:Mice; D008970:Molecular Weight; D011868:Radioisotopes; D012413:Rubidium; D013154:Spleen / Q000166:cytology; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology*
D005338:Fibrin Fibrinogen Degradation Products; D005768:Gastrointestinal Hormones; D007166:Immunosuppressive Agents; D008070:Lipopolysaccharides; D011868:Radioisotopes; D003208:Concanavalin A; D014660:Vasoactive Intestinal Peptide; D005340:Fibrinogen; D012413:Rubidium